Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGCG as Adjunct to Standard Iron Chelation in Thalassemia
TCTR20260711008Phase 2Not yet recruiting
- Sponsor
- Phramongkutklao Hospital Foundation
- Start
- Jul 2026
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epigallocatechin gallate in Thalassaemia, sponsored by Phramongkutklao Hospital Foundation. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
epigallocatechin gallate
03
Conditions
Thalassaemia
Beyond the preview
Go deeper on TCTR20260711008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260711008.